Xintela AB (XINT) - Total Liabilities

Latest as of September 2025: Skr36.95 Million SEK ≈ $3.98 Million USD

Based on the latest financial reports, Xintela AB (XINT) has total liabilities worth Skr36.95 Million SEK (≈ $3.98 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Xintela AB to assess how effectively this company generates cash.

Xintela AB - Total Liabilities Trend (2013–2024)

This chart illustrates how Xintela AB's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Xintela AB to evaluate the company's liquid asset resilience ratio.

Xintela AB Competitors by Total Liabilities

The table below lists competitors of Xintela AB ranked by their total liabilities.

Company	Country	Total Liabilities
Lead Real Estate Co., Ltd American Depositary Shares NASDAQ:LRE	USA	$107.94 Million
Apimeds Pharmaceuticals US, Inc. NYSE MKT:APUS	USA	$1.09 Million
Korean Air Lines Co Ltd KO:003495	Korea	₩38.95 Trillion
RNI Negócios Imobiliários S.A SA:RDNI3	Brazil	R$987.10 Million
Millcon Steel Public Company Limited BK:MILL	Thailand	฿15.38 Billion
Bull Will Co Ltd TWO:6259	Taiwan	NT$106.72 Million
Tips Films Limited NSE:TIPSFILMS	India	Rs1.95 Billion
Flexion Mobile PLC ST:FLEXM	Sweden	Skr20.59 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Xintela AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Xintela AB (XINT) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.09	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	4.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Xintela AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Xintela AB (2013–2024)

The table below shows the annual total liabilities of Xintela AB from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr30.75 Million ≈ $3.31 Million	+119.39%
2023-12-31	Skr14.02 Million ≈ $1.51 Million	-25.21%
2022-12-31	Skr18.74 Million ≈ $2.02 Million	-9.88%
2021-12-31	Skr20.80 Million ≈ $2.24 Million	-0.53%
2020-12-31	Skr20.91 Million ≈ $2.25 Million	+169.10%
2019-12-31	Skr7.77 Million ≈ $836.07K	+62.91%
2018-12-31	Skr4.77 Million ≈ $513.22K	-53.11%
2017-12-31	Skr10.17 Million ≈ $1.09 Million	+254.85%
2016-12-31	Skr2.87 Million ≈ $308.43K	-9.33%
2015-12-31	Skr3.16 Million ≈ $340.17K	+231.24%
2014-12-31	Skr954.29K ≈ $102.70K	-52.34%
2013-12-31	Skr2.00 Million ≈ $215.50K	--

About Xintela AB

ST:XINT Sweden Biotechnology

Market Cap

$17.71 Million

Skr164.59 Million SEK

Market Cap Rank

#25404 Global

#522 in Sweden

Share Price

Skr0.23

Change (1 day)

-1.68%

52-Week Range

Skr0.21 - Skr0.50

All Time High

Skr8.60